Our Research

Discover our recent findings, catch up with news, and review in-depth resources.

Globally Harmonized Labs

Leading the Way in Secure, Cross-Border Analytical Solutions. We’re committed to delivering seamless scientific expertise that’s globally integrated and locally specialized. 

ELISpot-Antigen Specific Response Assays

The ELISpot assay stands out as a highly sensitive technique for analyzing immune function. Find out more about Resolian’s capabilites here.

Biomarker Assay List

Our extensive biomarker method experience is outlined in the following list, but it’s not exhaustive.

Bioanalytical LC-MS/MS Assay List 

With 20+ years of working to GLP and GCP, we have developed an extensive number of LC-MS/MS bioanalytical methods in a wide range of species and matrices.

Immunoassay Pharmacokinetics

Resolian can support all your immunoassay bioanalytical requirements for toxicokinetics (TK) & pharmacokinetics (PK) data collection and interpretation…

Materials Characterization Testing Services

A detailed list of our Materials Characterization testing services.
Scroll to Top

Globally Harmonized Labs

Leading the Way in Secure, Cross-Border Analytical Solutions

At Resolian, our vision has always been about setting the global standard in laboratory solutions. With five labs worldwide, including our US-owned facility in China, we deliver secure, harmonized services designed to support your success across borders.

Our Chongqing lab operates on a western infrastructure, ensuring all client data is managed with stringent US and European frameworks. This means you get the reliability and security you expect, wherever you are in the world.

We’re committed to delivering seamless scientific expertise that’s globally integrated and locally specialized. 

Global Labs. Singular Framework

Min Meng

Chief Operations Officer.
President of Resolian APAC

I have worked for 25+ years in US CROs.
When we set up the China lab, we applied the same western operational framework to ensure seamless integration and top-tier service delivery for global clients.

Quality is Our Priority.
Across Our Global Labs.

Our Chongqing lab is fully integrated with Resolian’s global quality framework, ensuring adherence to the highest international standards. Alongside meeting international GLP and GCP requirements the lab is also ISO 9001 certified, following the same rigorous quality processes as all our sites, ensuring compliance with both Chinese regulatory agencies and global bodies like the FDA.

David Butler

Vice President
Corporate Quality

Proven Expertise. Globally Accredited. 

Our Chongqing lab holds global accreditations, meeting the highest regulatory standards, including US FDA compliance and China regulatory approvals, providing you with peace of mind wherever your projects take you.

  • FDA Regulatory Assessment Report
  • USFCR Verified Vendor
  • Successful FDA audit
  • Over 25 successful NMPA audits 

Secure Health Data.
Protected at Every Step.

Alex Paiva

Senior Director
Global Information Technology

Security is the foundation of our Global IT infrastructure. In Chongqing, our dedicated IT team works closely with Resolian’s global team to ensure secure, compliant management of sensitive health data, utilizing the latest in data protection technologies.

Your Goals. Our Science. 

Our lab in Chongqing offers a comprehensive range of services, designed to support your research and development goals, including:

  • GxP and non-regulated bioanalysis by LC-MS and Immunoassay
  • Biomarkers
  • Protein and oligonucleotide LC-MS
  • Antibody Drug Conjugates
  • mRNA assays

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now CEO at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.